Petros Pharmaceuticals, Inc. (PTPI) › Capital ExpendituresPetros Pharmaceuticals, Inc. (PTPI) — Capital ExpendituresAnnual figures by period end, from SEC filings.2020-12-31: $4.6K2024-12-31: $24.6K$24.6K2020-12-31Capital Expenditures (USD)2024-12-31Period endedCapital ExpendituresChange YoYSource filing2024-12-31$24.6K—2025-03-31From 2024-01-012020-12-31$4.6K—2022-03-31From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)